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ABSTRACT
Motivation: Cancer is an evolutionary process characterized by
accumulating mutations. However, the precise timing and the order
of genetic alterations that drive tumor progression remain enigmatic.
Results: We present a speciﬁc probabilistic graphical model
for the accumulation of mutations and their interdependencies.
The Bayesian network models cancer progression by an explicit
unobservable accumulation process in time that is separated from
the observable but error-prone detection of mutations. Model
parameters are estimated by an Expectation-Maximization algorithm
and the underlying interaction graph is obtained by a simulated
annealing procedure. Applying this method to cytogenetic data
for different cancer types, we ﬁnd multiple complex oncogenetic
pathways deviating substantially from simpliﬁed models, such as
linear pathways or trees. We further demonstrate how the inferred
progression dynamics can be used to improve genetics-based
survival predictions which could support diagnostics and prognosis.
Availability: The software package ct-cbn is available under a GPL
license on the web site cbg.ethz.ch/software/ct-cbn
Contact: moritz.gerstung@bsse.ethz.ch
1 INTRODUCTION
Cancer is a disease caused by alterations of the genome. Due
to systematic analyses of tumor genomes in the last decade it
became apparent that cancer is caused by the combined effect
of multiple mutations rather than single mutations (Hanahan and
Weinberg, 2000). These mutations accumulate slowly and tumors
grow over a period of multiple years. Ever since the classic
sequential diagrams of Fearon and Vogelstein (1990), researchers
have thus been interested in linking the progression of cancer with
the observed mutations. Because of the complexity of the mutation
data, however, the process of accumulating mutations is likely to be
more complex than what can be represented by a single path.
To account for this complexity, various mathematical and
statistical models have been derived to describe the genetic
progression of cancer. These models include oncogenetic trees
(Desper et al., 2000; Jiang et al., 2000; von Heydebreck et al.,
2004), tree mixtures (Beerenwinkel et al., 2005; Rahnenführer et al.,
2005), hidden trees (Tofigh, 2009), probabilistic network models
∗To whom correspondence should be addressed.
(Hjelm et al., 2006), principal components-based methods (Höglund
et al., 2001, 2005) and clustering approaches (Liu et al., 2006). The
latter two methods rely on general tools identifying the correlation
of data and representing it in graphical terms. Oncogenetic trees
and probabilistic network models, on the contrary, are generative
probabilistic models based on structural assumptions about the
carcinogenetic process in which mutations accumulate. Generalizing
the analyses of Fearon and Vogelstein (1990), tree models allow
for a branching of the accumulation process which gives rise to
different mutational pathways. The tree structure is still substantially
restricting the class of graphs, but enables efficient statistical
inference. A generalization of tree models is the conjunctive
Bayesian network (CBN; Beerenwinkel et al., 2006, 2007). The
associated graphs allow for multiple parental nodes thereby
modeling the synergistic effects of multiple events in promoting
subsequent mutations. The continuous time CBN (Beerenwinkel
and Sullivant, 2009) also includes an explicit timeline, making
quantitative predictions about the speed of carcinogenesis.
In this work, we extend the CBN by including an error model
accounting for observation errors arising from the limited resolution
of available clinical data or technical noise. Errors that occur during
the observation lead to a hidden accumulation process similar to a
hidden Markov model. We apply this method to publicly available
datasets from the Progenetix database (www.progenetix.net; Baudis
and Cleary, 2001) and compare the results for different cancer types.
We show that the resulting graphs deviate substantially from classic
linear diagrams and from oncogenetic trees, therefore indicating a
high degree of genetic complexity in the process of carcinogenesis.
2 METHODS
Our statistical model for the accumulation and detection of mutations is a
specific Bayesian network, where the accumulation of mutations is modeled
by a CBN. The CBN dynamics is hidden by an observation process; we
therefore term the model hidden CBN (H-CBN). For the H-CBN, we
derive an expectation-maximatization (EM) algorithm for the estimation
of the continuous model parameters. Furthermore, we propose a simulated
annealing algorithm to find the graph that maximizes the likelihood of the
data.
2.1 Bayesian networks and the detection of cancer
The clinical detection of a tumor is a complex process, which, in the
reductionist view, contains three elements: (i) the malignancy has developed;
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Fig. 1. (A) Simple Bayesian network for cancer detection. T denotes the
waiting time for the tumor, Ts the time of diagnosis. The disease is present,
X =1, if T <Ts. Yet the diagnosis Y may contain errors. (B) Graph of an
H-CBN example. The waiting times Ti of the mutations i=1,...,4 evolve
according to the CBN depicted in the upper left: mutations 1 and 2 arise
independently; mutation 3 can only occur after 1, T1 <T3, mutation 4
occurs only if both 1 and 2 are present, T1,T2 <T4. A mutation i is present
in the genotype X = (X1,...,X4) if Ti <Ts, where Ts is the independent
stopping time. The observations Y = (Y1, ...,Y4) contain errors that occur
independently for each mutation.
(ii) it is diagnosed in a clinical test; and (iii) the test is correct. Formalizing
these notions, we define the following model: suppose the tumor develops
in an initially healthy tissue after a time T . The waiting time is a random
variable, because the exact occurrence of the tumor varies across patients.
Diagnosis occurs at time Ts, which is also a random variable. Because
the dependence of T and Ts is generally unknown, we assume that Ts is
independent of T . Hence, the joint density factorizes, f (t,ts)= f (t)f (ts). The
disease can only be detected if it is present at the time of observation. Let
X ∈{0,1} denote the stochastic variable indicating whether the disease is
present at diagnosis (X =1). The probability of X can be decomposed in a
Bayesian fashion as
Prob[X]=
∫ ∞
0
∫ ∞
0
Prob[X |T = t,Ts = ts]f (t)f (ts)d td ts, (1)
where the conditional probability Prob[X =1 |T = t,Ts = ts]=I(t < ts) is
simply given by the indicator function I.
So far we have assumed that the diagnosis is always correct. Suppose that,
with a small probability , the disease might be overlooked (false negative)
or misdiagnosed (false positive). Hence, the diagnosis is a probabilistic event
Y that depends on X as Prob[Y ]=∑X=0,1 Prob[Y |X]Prob[X], with
Prob[Y |X]=I(Y =X)(1−)I(Y=X), (2)
and Prob[X] as defined in Equation (1).
The stochastic variables {T ,Ts,X,Y} form a Bayesian network: the joint
density factors into conditional densities according to the directed acyclic
graph (DAG) shown in Figure 1A.
2.2 Conjunctive Bayesian networks
We now extend our model for the development of cancer. This process
is driven by the accumulation of several genetic lesions. We therefore
generalize the waiting time T = (T1,...,Tn) to incorporate the occurrence
of n mutations. A model for the accumulation of multiple, possibly collinear
mutations, is the CBN (Beerenwinkel and Sullivant, 2009).
Let n be the total number of possible mutations and define Ti as the waiting
time for mutation i∈{1,...,n}=[n]. Furthermore, let pa(i) denote the set of
mutations that need to be present before mutation i can fixate. We define Ti to
be exponentially distributed with parameter λi conditioned on all mutations
pa(i) being present,
Ti ∼Exp(λi)+ maxj∈pa(i)Tj . (3)
The density of Ti, conditioned on the predecessors {Tj}j∈pa(i), is
fTi |{Tj}j∈pa(i) (ti | {tj})=λi exp
(−λi(ti − maxj∈pa(i)tj)
)
I
(
ti > maxj∈pa(i)
tj
)
, (4)
where I denotes the indicator function. The set of waiting times {Ti}i∈[n]
forms a CBN with a partial temporal order Tj <Ti for all j∈pa(i) and all i∈
[n]. The underlying algebraic structure of the mutations is a partially ordered
set (poset) P, with the cover relations j→ i for j∈pa(i). The cover relations
of P correspond to the directed edges in the graph of the Bayesian network
as illustrated in Figure 1B (top left). For the censoring, we assume that the
waiting time Ts is independently exponentially distributed with parameter λs,
Ts ∼Exp(λs). We thus extend the poset P by the stopping event s, which does
not have any order relation to the mutations i. This assumption resembles
that the time of diagnosis is not bound to the presence of mutations.
In the previous section, we have introduced X as the binary event that
the disease is present. Since we are now considering multiple mutations
characterizing the transformation to malignancy, stopping generates a
binary vector X = (X1,...,Xn)∈{0,1}n, the genotype of the tumor. Using
that the conditional density of X factorizes according to the Bayesian
network structure, Prob[X |T ,Ts]=∏ni=1 Prob[Xi |Ti,Ts] and Equation (1)
one obtains:
Probλ,P[X]=Probλ,P
[
max
i:Xi=1
Ti <Ts < minj:Xj=0
Tj
]
. (5)
Probλ,P [X] is invariant under rescalings of λ= (λs,λ1,...,λn); hence
λi, i∈[n], can only be estimated up to the factor λs. Unless λs is known,
we set λs =1.
2.2.1 H-CBN Parameter estimation for the CBN requires that all
mutations Xi are identified correctly. Because of experimental limitations,
however, the observed genotype Y = (Y1,...,Yn) might contain errors. This
could be because either a mutation is not functional (false positive) or below
the limit of detection (false negative). We model the observation process
by assuming that a mutation i is falsely observed with probability  as in
Equation (2). Because the conditioned variables Yi|Xi are independent for
each i∈[n], the conditional probability of an observation Y given a genotype
X is:
Prob[Y |X]=
n∏
i=1
Prob[Yi |Xi]=d(X,Y )(1−)n−d(X,Y ). (6)
Here d(X,Y )=∑ni=1 |Xi −Yi| denotes the Hamming distance between the
genotype X and the observation Y . Hence, the dynamics of the accumulation
process is a hidden process by two means: first, the dynamics is censored by
a stopping process, and second, the observation contains errors. A schematic
illustration of the H-CBN is shown in Figure 1B: the process of mutating
is described by the waiting times Ti evolving according to partial order
constraints. Genotypes X are generated by the censoring caused by Ts. Note
that the mutations Xi are independent, conditioned on Ti and Ts. Finally, the
observation process is erroneous, generating the observations Yi.
To estimate the model parameters, we must compute the posterior
probability of observing the genotype X given an observation Y . The
posterior can be computed by Bayes’ theorem:
Prob,λ,P[X |Y ]= Probλ,P[X]Prob[Y |X]∑
X∈J(P) Probλ,P[X]Prob[Y |X]
. (7)
Here, Probλ,P[X] denotes the prior probability that the genotype X occurs
according to Equation (5); J(P) is the lattice of order ideals, containing all
genotypes compatible with the poset P (Beerenwinkel et al., 2007).
2.3 Parameter estimation
Although the dynamics of the H-CBN can only indirectly be observed, the
model parameters  and λ can be estimated by an EM algorithm. To estimate
the set of relations P, we propose the method of simulated annealing.
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2.3.1 EM algorithm The joint probability of N independent
observations Y= (Y (1),...,Y (N)) factorizes into the product Prob,λ,P[Y]=∏N
l=1 Prob,λ,P[Y (l)]=
∏N
l=1
∑
X∈J(P) Prob[Y (l) |X]Probλ,P[X].
Hence, the log-likelihood of the data is:
Y(,λ,P)=
N∑
l=1
log
[ ∑
X∈J(P)
d(X,Y
(l))(1−)n−d(X,Y (l)) Probλ,P[X]
]
. (8)
We are interested in maximizing the log-likelihood Y(,λ,P) given
observations Y. The likelihood depends on the observation error rate ,
the waiting time parameters λ and the relations in P. The parameters
λ could be estimated by an EM algorithm if P and the true genotypes
X= (X (1),...,X (N)) were known. In the case of hidden X and fixed P, this
method can be embedded into a nested EM algorithm. The outer loop
computes the parameter estimate λˆ and the inner loop computes the error
rate estimate ˆ given the iterated value λˆ(k).
If both X and Y were known, the maximum likelihood (ML) estimator
of the observation error rate would be the average distance per mutation,
ˆ=∑Nl=1 d(X (l),Y (l))/(nN). Because X is hidden, ˆ is computed iteratively by
using the conditional expectation of the sufficient statistic d(X,Y (l)) (E-step)
for computing the ML estimate (M-step):
ˆ(j+1) = 1
nN
N∑
l=1
∑
X∈J(P)
d(X,Y (l))Probˆ(j),λˆ(k),P[X|Y (l)]. (9)
Doing this until the convergence yields an estimator ˆ that locally maximizes
Y(,λˆ(k),P); this value is in turn used to estimate λ.
For N realizations of the waiting times Ti, the ML estimator of the
parameter λi is (Beerenwinkel and Sullivant, 2009):
λˆi = N∑N
l=1(T (l)i −maxj∈pa(i) T (l)j )
. (10)
As the waiting times Ti are censored, the denominator is replaced by the
expected sufficient statistic Eλˆ(k),ˆ,P[Ti −maxj∈pa(i) Tj |Y (l)] in the E-step of
the outer EM algorithm. These values are computed from the Bayesian
decomposition:
Eλˆ(k),ˆ,P[Ti − max
m∈pa(i)
Tm|Y (l)]
=
∑
X∈J(P)
Eλˆ(k),P[Ti − max
m∈pa(i)
Tm|X]Probˆ,λˆ(k),P[X|Y (l)]. (11)
The expectations Eλˆ(k),P[Ti −maxm∈pa(i) Tm|X] can be computed by dynamic
programming. Yet, they need to be computed for all possible values of the
hidden genotypes X ∈J(P), imposing computational limitations in the case
of many mutations. In the M-step of the outer EM-loop, the expected values
in Equation (11) are then used for computing the next iteration step λˆ(k+1)
according to Equation (10). Iterating until the changes in λˆ(k) are sufficiently
small gives the estimator λˆ.
2.3.2 Simulated annealing The EM algorithm locally maximizes the log-
likelihood of the data, Equation (8), for a given poset P. In most of the
situations, however, one is mainly interested in inferring P. Because the
number of continuous parameters λi is fixed by the number of mutations
and not by the number of relations in P, all models have the same degree
of freedom. Therefore, we select the ML poset Pˆ=argmaxPY(ˆ,λˆ,P)
without an additional model selection criterion such as the Akaike or
Bayesian information criterion (AIC and BIC, respectively). Yet due to
the observation errors, there exists no direct analytical way to determine
Pˆ. Instead, we have to rely on heuristic ways to find the ML estimate.
We do so by using a simulated annealing procedure (Kirkpatrick et al.,
1983). In this algorithm, one computes Y(ˆ,λˆ,P) for a given poset P
and the data Y; one then randomly generates a new poset P′ and accepts
this if either Y(ˆ,λˆ,P′)>Y(ˆ,λˆ,P) or, alternatively, with probability
exp(−[Y(ˆ,λˆ,P)−Y(ˆ,λˆ,P′)]/T ). The temperature T determines to which
extend steps decreasing the log-likelihood are allowed, thus reducing the risk
of remaining in local maxima. As T →0 only steps increasing Y(ˆ,λˆ,P) are
accepted.
The efficiency of the algorithm relies on an adequate strategy for choosing
the new poset P′. Our algorithm randomly removes or adds a cover relation
to P. Because a poset defines a special DAG, we only consider the addition of
relations yielding another poset. As the occurrence of a relation relies on the
correlation of the observed data, we also allow for changing the direction of a
relation. Moreover, a sequence i→k → j can be replaced by i→k and i→ j,
thereby changing two relations at once. To avoid inefficient moves, we use
a preselection heuristic based on the fraction of data ρ without observation
errors, which is a proxy for the likelihood. This computation is very fast
as it does not require the nested EM algorithm. Moves are preselected
with probability exp(−[ρ−ρ′]/0.05) if ρ′ <ρ and 1 otherwise. For moves
having passed preselection, we then compute Y(ˆ,λˆ,P′) and proceed with
the algorithm as stated above.
3 RESULTS
We first present results on simulated datasets illustrating the power of
the algorithm. We then analyze cytogenetic data for different cancer
types and demonstrate how the evolutionary model can be used for
an improved survival analysis.
3.1 Simulations
To test our algorithms, we simulated data for different posets and
parameter values of . We simulated 50 datasets each with N =800
observations and n=12 mutations. For , we chose parameter values
of 0.01 and 0.1, respectively; for λ we used random values. As
posets we selected the completely independent case, a linear chain
1→2→ ..., and two more complex posets shown in Figure 2A.
The simulations show that for a known poset P, the estimation
of the error rate  is highly accurate for both parameter values,
with the highest variance arising in the independent case (Fig. 2B).
The variance increases if the poset is also estimated by simulated
annealing (Fig. 2C). Again the variance is largest in the independent
cases with a bias toward larger values. For all other, more realistic,
posets, however, the estimation of  is very accurate. The same
holds for the estimation of the waiting time parameters λ. The
estimates after the annealing process have low variance, as long
as the expected frequencies are larger than the noise level , as
shown for poset 1 in Figure 2D (with similar results for poset 2).
Outliers arise, most likely, if the estimated order relations of the
corresponding mutations contain errors. If the noise level exceeds
the expected frequency of a mutation, the variance of the associated
waiting time estimator becomes large, because the true frequency
cannot be accurately recovered. This is the case for the late-stage
mutations 10, 11 and 12, as depicted in Figure 2D.
Slightly more complicated than estimating the parameters is
finding the ML poset Pˆ. The number of relations in a poset
is given by the transitive closure of the cover relations, which
are represented by edges in the corresponding DAG. The linear
poset, for example, has exactly n−1 cover relations, but these
sum up to a total number of r0 =n(n−1)/2 relations. This
number r0 is the maximal number of relations that can be found
in any poset. We thus define the observed false positive rate
(FPR)= (# relations in Pˆ but not in P)/r0, and the false negative
rate (FNR)= (# relations in P but not in Pˆ)/(# relations in P).
For all four structures, the estimation of P is very precise for
=0.01, with median error rates < 0.05 (Fig. 2E). The distribution
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Fig. 2. Estimation on simulated data. (A) Simulated poset structures. (B) Boxplots of the estimates ˆ for the true poset P. True parameter values are indicated
by asterisks. (C) Distributions of the estimates ˆ after estimating the poset. (D) Boxplots of the waiting time parameter estimates λˆ for the estimates of poset 1.
(E) Boxplots of the numerically observed FPR and FNR for two values of . The sample size was N =800, and B=50 runs were performed.
of false positive and false negative relations depends on the specific
poset. For the independent case, the FNR is zero by definition, for
the other posets both types of errors are possible. Both types of
errors increase for the larger error rate, =0.1. In this case, we find
median error rates of ∼0.1–0.2. Both the FPR and FNR increase
monotonically as compared with their values at =0.01, showing
that the structure imposes a distinct bias. The highest errors arise in
the estimation of poset 1, which has the most complex structure. But
still the median error rates are <17%. Importantly, the estimation of
the error rate  remains realistic despite inaccuracies in Pˆ (Fig. 2C),
making it possible to identify noisy data even without complete
knowledge of the true poset.
3.2 Renal cell carcinoma
Today, there exists a wealth of data on genetic alterations in
cancer. The largest resource for whole-genome aberration data
so far has been generated through cytogenetic (Mitelman et al.,
2009) or molecular cytogenetic, e.g. chromosomal and array-based
comparative genomic hybridization (CGH), techniques. Here, we
apply our method to disease-specific CGH data from the Progenetix
database (www.progenetix.net; Baudis and Cleary, 2001). A
descriptive analysis of this data can be found in Baudis (2007).
We first apply our method to a dataset on renal cell carcinoma
(RCC) from the Progenetix database. This dataset (N =251) has
been published in parts before (Jiang et al., 2000), and contains
clinical follow-up on patient survival for 82 cases. The most frequent
losses for this cancer type are: –3p (59.4 %), –4q (29.9%), –6q
(25.5%), –9p (24.4 %), –13q (23.1%), –14q (17.9 %), –8p (16.3%)
and –18q (14.7%). Characteristic is the loss of the p arm on
chromosome 3, which hosts the VHL gene, an important tumor
suppressor. The most frequent gains are: +5q(31) (25.2%), +17q
(21.2 %) and +7 (21.2%).
For our analysis, we restrict ourselves to the n=12 copy number
alterations (CNAs) used by Jiang et al. (2000), which were selected
by the method of Brodeur et al. (1982). These do not include the
gain of chromosome 5p and the loss on 14q. Instead, the alterations
of the X chromosome –X(p) (10.0%; often whole chromosome) and
+X(p) (9.6%; often whole chromosome) get selected, as well as
the gain on chromosome 17p (13.5%). Somewhat surprisingly, the
estimated ML poset (ˆ=0.01) contains only two relations, –4q →
–4p and +17q → +17p. That is, loss of 4q appears before the loss
of the additional chromosome arm 4p, or the whole chromosome.
The second relation exists between gain of chromosome 17q and
the gain on the opposing chromosome arm. This could be the
result of aneuploidy of chromosome 17, or of gains spanning both
chromosome arms.
Comparing this result with the oncogenetic tree models of Jiang
et al. (2000), one finds that the tree contains more relations,
but it also has a much smaller likelihood (likelihood ratio =
ProbPJiang [Y]/ProbPˆ[Y]=3·10−10). Interestingly, the tree occurs
close to a local maximum of the likelihood. Performing a local
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Fig. 3. Renal cell carcinoma. Locally optimal poset close to the tree of Jiang
et al. (2000). Nodes correspond to specific recurrent mutations (20%).
Small numbers at each edge denote the fold change  of the likelihood if
the corresponding relation is left out.
search for the ML H-CBN starting from the tree revealed a poset with
=0.004 (=0.08; Fig. 3). This value is on the order of changes of
a single relation, hence the statistical difference is small. Moreover,
the relations appear to be in better agreement with the pathways
reported previously in the literature. For example, it is known that the
VHL gene on 3p plays an important initializing role in RCC (Gnarra
et al., 1994). In the poset shown in Figure 3, the initializing events
are –3p and –4q. The mutation –3p induces a pathway including
–9p and –18q, which has been previously reported by Höglund et al.
(2004). A second pathway involves both –3p and –4q, which induce
–4p and –6q, as well as +17q and –13q, ultimately leading to –Xp.
This progression is similar to the one proposed by the tree models
of Jiang et al. (2000); yet the poset includes nodes with multiple
incoming edges such as –Xp or –6q, which cannot be represented
by a tree. In the analysis of Höglund et al. (2004), the losses on
chromosome 4 are, in general, a late-stage event. Our approach
recovers the same grouping, but assigns an initializing role to –4q,
in agreement with the work of (Jiang et al., 2000). Höglund et al.
(2004) also report an independent pathway involving the gains on
chromosome 17, eventually leading to –4. Our analysis suggests
that those alterations occur independently from –3p, but only after
being initialized by –4q. Note, however, that the likelihood ratios
of some edges are relative large; hence the statistical evidence for
those relations is weak.
3.2.1 Survival analysis For 82 cases of the RCC dataset, clinical
follow-up data with survival information was available. The standard
method for survival analysis is the Cox proportional hazards model
(Cox, 1972). Here, the risk associated with a genotype X is given
by the hazard function
λ(t)=λ0(t)exp(βX), (12)
where λ0(t) denotes the baseline hazard. The contribution of each
mutation to the risk is given by the coefficients β, which are
estimated from the survival data. A multivariate survival analysis
on all 12 CNAs does not reveal a significant association of any of
the selected CNAs with survival (P=0.185, likelihood ratio test).
This might be due to erroneous observations. We therefore calculated
the maximum a posteriori (MAP) estimator X˜= (X˜(1),...,X˜(N)) of
the hidden data X. For each observation Y (l), it is defined as:
X˜(l) =arg max
X∈J(Pˆ)
ProbPˆ,ˆ,λˆ[X |Y (l)], (13)
where λˆ, and ˆ are the model parameters estimated on the complete
dataset (N =251). Based on the dynamics of the CBN, this strategy
selects the most probable hidden genotype. For the sparse poset,
Table 1. Average distances (in percent) of the estimated hidden data to the
observed data, Y−X˜, for the RCC poset shown in Figure 3
–3p –4p –4q –6q –8p –9p –13q –18q –Xp +17p +17q +Xp
–2 1 –2 8 3 4 6 7 7 5 6 6
Fig. 4. Kaplan–Meier plot of the RCC dataset. Shown are three risk groups
according to the coefficients βX˜ from the LASSO selection in the Cox
model. X˜ denotes the MAP estimate of the hidden genotypes.
the MAP estimates are almost identical to the observations (mean
Hamming distance d¯ =0.03, maximal distance dmax =1). The
poset shown in Figure 3 introduces a stronger deviation (d¯ =0.56,
dmax = 4). The average distances per mutation are denoted in
Table 1. Interestingly, most CNAs have a higher frequency in the
observed data, except for –3p and –4q. This effect could be a result
of the coarse-graining to chromosome arms, which erroneously
includes alterations in non-functional bands.
Re-estimating the risk coefficients for the estimated hidden
data X˜(l), we find a somewhat stronger overall effect (P=0.10;
likelihood ratio test). To pinpoint the relevant CNAs, we selected
the best covariate subset by applying a LASSO version of the
Cox proportional hazards model (Park and Hastie, 2007; Tibshirani,
1997). Here, the sparseness of the solution can be controlled, by
imposing an L1 penalty on the likelihood. The optimal penalization
parameter is chosen by maximization of the cross-validated partial
likelihood. Applying this method to the estimated hidden data X˜
reveals a combination of –3p, –4q and –Xp as the best predictor
subset. This result is confirmed by the subsets selected by the BIC
(excluding –Xp) and AIC (including –6q) model selection criteria.
For the LASSO selection, the risk is balanced between the relieving
effect of –3p (βˆi =−1.55) and the malignant effects of –4q and
–Xp (βˆi =1.43 and βˆi =0.93, respectively). A positive effect of VHL
mutations on 3p has been reported previously for clear-cell RCC
(Yao et al., 2002). The Kaplan–Meyer plot of the data is shown
in Figure 4. Depicted are three groups according to the overall
risk given by Equation (12) with the LASSO estimates βˆ and the
MAP covariates X˜. The groups are clearly separated with 5 year
survival rate of <20% for patients in the highest risk group. On the
contrary, those in the lowest risk group have a 10 year survival of
70%. Similar results are obtained using the posterior expectations
E[X |Y (l)] instead of the MAP estimates (data not shown).
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Fig. 5. Estimated posets for breast cancer (A) and colorectal cancer (B).
Nodes correspond to specific recurrent mutations (20%). Numbers at each
edge denote the likelihood change  if the corresponding relation is left out.
3.3 Breast and colorectal cancer
We continue by exploring the poset structure of other cancer data
available in the Progenetix database. For this purpose, we chose
breast and colorectal cancer as two prominent examples.
3.3.1 Breast cancer The data for breast cancer found in the
Progenetix database consists of 817 cases. The most frequent (>20%)
gains are: +1(q31) (59.7%), +8(q23) (48.0%), +17q (36.2%), +20(q)
(31.7%), +16(p) (25.1%), +11q13 (24.5%) and +3q (22.4%). Highly
recurrent losses (>20%) are: –16(q) (29.0%), –8p (27.8%) and –
13q (24.7%). The graph of the ML poset (ˆ=0.15) estimated by
our method is shown in Figure 5A. The gain +1q acts as a central
initializing event, inducing –8p, +3q and –16q in conjunction with
+8q. Independently of this pathway, there exists a pathway involving
+17q, +16p, +20q and –13q.
The +1q/+8q pathway corresponds roughly to a previously
reported path of breast cancer (Höglund et al., 2002b). A putative
oncogene on chromosome arm 8q is MYC. Despite its high
recurrence, there is no obvious candidate oncogene on chromosome
1q. Furthermore, the progression into the –16q state has been
associated with high differentiation and good prognosis (Roylance
et al., 1999). The initializing event of the latter path, 17q, is the
locus of ERBB2, a well-known oncogene; typically gains of this
chromosome correspond to a poor prognosis (Buerger et al., 1999).
Targets on 20q and 13q are AURKA and BRCA2, respectively, which
are both involved in the maintenance of genome stability.
3.3.2 Colon cancer For colorectal cancer, 570 cases were filed in
the Progenetix database. The gains recurring most frequently (20)
are: +20(q13) (46.7%), +13q (37.9%), +8(q24), +7(q) (32.8%) and
+X(q24) (30.4%). The most frequent losses are: –18(q22) (44.4%),
–8p(22) (34.2%), –17p12 (25.3%), –4(q) (23.3%), –15q (19.2%) and
–1p (18.8%). The estimated poset (ˆ=0.11) is shown in Figure 5B.
For this type of cancer, +20q appears to be the central initializing
event. This chromosome arm harbors the putative oncogene AURKA,
which is known to cause genetic instability (Bischoff et al., 1998).
This instability-causing role agrees well with an initializing role
found by our approach. Loss of 18q then appears to play a central
role in the upcoming stages of tumor progression by triggering a
variety of subsequent losses. The q arm of chromosome 18 is locus
of the tumor suppressor SMAD4, which indicates an important role
in tumor development.
This result agrees with previous findings based on PCA (Höglund
et al., 2002a). Those authors report two overlapping pathways
in colorectal tumors, one dominated by losses, the other mostly
involving chromosomal gains, whereas for adenomas, the patterns
are less clear. In the gain pathway, an intermediate role was assigned
to +20q, whereas in our analysis it is a main trigger in agreement with
its putative biological role. The other pathway reported by Höglund
et al. (2002a) is triggered by –1p and involves –17p, –8p, –18q and
–15q as downstream events. Our analysis recovers this grouping,
however, in the opposite order: –18q induces the other alterations.
Our model also elucidates a possible overlap of the two pathways
through the events –18q and +8q.
4 DISCUSSION
We have developed a statistical method for the inference of
partial temporal orders of cancer mutations. Our method is based
on a waiting time model of cancer progression allowing for
temporal constraints in terms of a continuous time CBN. We have
extended this model to account for observation errors and presented
algorithms to infer the ML model parameters.
Similar to the CBN, oncogenetic trees were developed to model
the dependencies among accumulating mutations (Desper et al.,
2000; Jiang et al., 2000; von Heydebreck et al., 2004). H-CBN
extends the concept of oncogenetic trees in two ways: first, the CBN
substantially extends the class of possible graphs by allowing for
more than one parent per node. Biologically this allows to include
direct dependencies on multiple mutations. Second, H-CBN includes
an observation process. Therefore, a fraction of data deviating from
the CBN can be explained by observation errors. It thus provides a
direct interpretation for the fraction of data not matching the graph.
This is in contrast with mixture models, where the mixture process
is less intuitive. Another interpretation of our error model is that it
enables approximating more general accumulation processes by the
closest CBN.
A further improvement on our model could be to use different
parameters + and − for false positives and false negatives
in the error model, as used in the context of longitudinal data
(Beerenwinkel and Drton, 2007). This would refine the error
process and give more detailed information about the nature of
mismatches. Another modification of the model would be to use
disjunctive instead of a conjunctive action of multiple incoming
edges (Beerenwinkel et al., 2006). This model would drastically
enlarge the class of possible graphs; however, we would expect only
a limited statistical power given the size of available data. The same
limitation would also apply to a full Bayesian network approach on
the complete set of DAGs.
Our analysis of cancer CGH data reveals complex structures
of cancer progression. Our results indicate that there typically
exist multiple independent events triggering complex downstream
pathways. This generalizes the classic sequential model of cancer
progression by Fearon and Vogelstein (1990). For the RCC dataset,
we have also shown that the prognostic value of CNAs can be
increased by correcting for observation errors using the MAP
estimates of the genotypes. This approach revealed the combination
of –4q, –3p and –Xp as the best genetic predictor subset for RCC.
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Hidden conjunctive Bayesian networks
In this work, we have applied our data to available CGH mutation
data. This data is binary and simply denotes the presence of a certain
chromosomal alteration. Due to the limited resolution, however,
important information about small-scale mutation such as point
mutations may be missing. Also epigenetic information is not
covered. We emphasize that our method is in principle suitable for
the analysis of such data, including data on differentially expressed
genes. Also clinical variables like treatment, tumor subtypes and
patient information can be easily integrated into our Bayesian
network approach.
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